Hematologic cancers begin in blood-forming tissue. They usually form in the bone marrow or cells of the immune system. Also called blood cancer, they include cancers such as leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and other plasma cell disorders.
We also treat non-cancerous bleeding and clotting conditions, factor deficiencies, hemoglobinopathies, and other abnormalities of the blood and bone marrow components.
Someone is diagnosed with a blood cancer about every four minutes in America. There are more than 200,000 new cases each year. At Sylvester, if you have a diagnosis of a blood cancer, you have immediate access to South Florida's most experienced team with the best patient outcomes. Our cancer physician-experts are members of one of the nation's top academic cancer centers. Our single focus is the prevention, diagnosis, and treatment of blood cancer.
Conditions and Treatments
Non-cancerous Hematologic Conditions and Treatments
Why Choose Sylvester Comprehensive Cancer Center?
Sylvester is an NCI-designated cancer center. The National Cancer Institute has recognized Sylvester for its outstanding work conducting research in its laboratories, treating patients in its clinics and hospitals, and reaching out to medically underserved communities with innovative prevention strategies.
The Cancer Epigenetics (CE) Research Program was established in 2014 at Sylvester and has become one of the leading programs in the country, actively translating discoveries into clinical trials. Its goal is to incorporate basic and clinical research in the field of cancer epigenetics. The program focuses on identifying epigenetic mechanisms regulating cancer initiation and progression. It also launches tailored epigenetic therapies to treat cancer, testing them in pre-clinical and clinical studies. The collaborative CE investigators are working to pinpoint the factors that contribute to the probability, progression, treatment, and ultimately, cure of your cancer. By identifying these mechanisms, they can get new targeted treatments to the clinical area faster.
OnControl® bone marrow sampling device: Developed by one of our oncologists, the powered hand-held device provides for controlled, consistent bone marrow samples for diagnosis and treatment monitoring. It obtains representative bone marrow samples in less than five minutes with less pain for an accurate diagnosis the first time.
More cancer clinical trials than any other South Florida hospital. If appropriate for your cancer and stage, our clinical trials provide you with the very newest ways to treat and potentially cure your cancer.
One of only six designated Cancer Centers of Excellence in Florida. We treat cancer and only cancer, giving you the best potential outcomes. The likelihood of surviving cancer after five years at a Dedicated Cancer Center is 17 percent higher than at other hospitals.
Internationally-recognized expertise in caring for patients with common and rare hematologic conditions. Our faculty are leaders in the education of students, trainees, colleagues, and patients. They are frequently invited to lecture nationally and internationally, and have authored U.S. and worldwide guidelines on the treatment of blood and bone marrow disorders.
Advanced radiation therapy options like RapidArc®, offering intensity modulated external radiation therapy (IMRT). Our leading-edge technology offers more efficient and effective treatments, shorter treatment times, improved accuracy in cancer targeting and less damage to surrounding healthy tissue.
Questions? We're here to help.
Our appointment specialists are ready to help you find what you need. Contact us today.